5-MeO-MiPT

5-MeO-MiPT
Clinical data
Other names	Moxy; MSD-001; MSD001; 5-Methoxy-N-methyl-N-isopropyltryptamine
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); UK: Class A;
Identifiers
	IUPAC name N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amine;
CAS Number	96096-55-8 ;
PubChem CID	2763156;
ChemSpider	2043845 ;
UNII	L0P1807EUY;
ChEMBL	ChEMBL172139 ;
CompTox Dashboard (EPA)	DTXSID90242114 ;
ECHA InfoCard	100.223.426
Chemical and physical data
Formula	C15H22N2O
Molar mass	246.354 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O(c1cc2c(cc1)[nH]cc2CCN(C(C)C)C)C;
	InChI InChI=1S/C15H22N2O/c1-11(2)17(3)8-7-12-10-16-15-6-5-13(18-4)9-14(12)15/h5-6,9-11,16H,7-8H2,1-4H3 ; Key:HEDOODBJFVUQMS-UHFFFAOYSA-N ;
	(verify)

5-MeO-MiPT is a psychedelic and hallucinogen of the tryptamine family. It used by some as an entheogen. It has structural and pharmacodynamic properties similar to the drugs 5-MeO-DiPT, DiPT, and MiPT.

5-MeO-MiPT was first described in the scientific literature by Alexander Shulgin and colleagues in 1985.